A recent study published in Oncology Letters, discusses the importance of effective therapy management of sunitinib (Sutent) in order to obtain maximum clinical benefit, which includes adequate side effects management and optimization of dosing and treatment duration.
The study describes three clinical cases in which therapy with sunitinib was continued by adopting alternative reduced schedules or an additional loco-regional treatment in order to manage toxicities or overcome progressive disease.
Here is an excerpt of an abstract from PubMed:
Effective therapy management is essential to obtain the maximum clinical benefit, and includes adequate side effect management as well as optimization of dosing and treatment duration. In the current study, examples of maximization of treatment with sunitinib are presented, describing three clinical cases in which therapy with sunitinib was continued via the adoption of alternative reduced schedules or an additional loco-regional treatment, in order to manage toxicities or overcome progressive disease.
